Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Tripartite motif-containing protein 43 (TRIM43) is a member of the TRIM family of E3 ubiquitin ligases, characterized by N-terminal RING, B-box, and coiled-coil domains. It localizes predominantly to the cytoplasm and the centrosome. TRIM43 regulates the structural integrity of the centrosome and nuclear lamina by mediating the ubiquitination and proteasomal degradation of pericentrin during herpesvirus infections. This activity restricts herpesviral replication by altering the nuclear environment required for viral chromatin transcription, positioning TRIM43 as a host restriction factor with roles in intrinsic antiviral immunity. It is implicated in the pathogenesis of herpesvirus infections and is associated with regulating gene expression via its effects on nuclear architecture. Mutations or dysregulation in TRIM43 are linked to diseases such as facioscapulohumeral muscular dystrophy and possibly cancer[1][2][3][6][7][10].
Ubiquitination-dependent proteasomal degradation (notably of pericentrin, leading to repression of active viral chromatin during herpesvirus infection)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tripartite motif-containing protein 43 (TRIM43).